Medpage Today on MSN
De-Escalating Bone-Modifying Therapy Safe, Effective in Metastatic Breast Cancer
BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback